Tregalizumab

From WikiMD.org
Jump to navigation Jump to search

Tregalizumab

Tregalizumab (pronounced: tre-ga-li-zu-mab) is a monoclonal antibody designed for the treatment of autoimmune diseases and HIV.

Etymology

The name "Tregalizumab" is derived from the term "T-regulatory cells" or "Tregs", a type of white blood cell that the drug targets, and "-lizumab", a common suffix for monoclonal antibodies.

Function

Tregalizumab works by selectively activating regulatory T cells, a type of white blood cell that plays a key role in maintaining immune system balance. By boosting the activity of these cells, Tregalizumab can help to control overactive immune responses that are characteristic of autoimmune diseases.

Clinical Trials

Tregalizumab has undergone clinical trials for the treatment of rheumatoid arthritis, an autoimmune disease that causes inflammation and damage to the joints. However, the results of these trials have been mixed, and further research is needed to determine the drug's efficacy and safety profile.

Related Terms

  • Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
  • Autoimmune disease: A condition in which your immune system mistakenly attacks your body.
  • HIV: A virus that attacks the body's immune system.
  • White blood cell: Cells of the immune system that are involved in protecting the body against both infectious disease and foreign invaders.
  • Clinical trials: Research studies performed in people that are aimed at evaluating a medical, surgical, or behavioral intervention.
  • Rheumatoid arthritis: A chronic inflammatory disorder affecting many joints, including those in the hands and feet.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski